Results 211 to 220 of about 15,392,732 (265)

Causal analysis of trade loss from pathogens: A global study of foot and mouth disease impacts on meat exports

American Journal of Agricultural Economics, EarlyView.
Abstract Our general interest is in global trade loss from livestock pathogens, specifically exports. We adopt a causal inference approach that considers animal disease outbreaks over time as non‐staggered binary treatments with the potential for switching in (infection) and out of treatment (recovery) within the sample period. The outcome evolution of
Mohammad Maksudur Rahman, Thomas L. Marsh   +1 more
wiley   +1 more source

Emerging Novel SARS-CoV-2 Subvariants and the Advantages of AI-ML in Deciphering the Mutation Trends, Genomic Surveillance and Vaccine Development. [PDF]

Health Sci Rep
Rout A, Das K, Sarangi AK, Mishra S, Mohanty C, Singh PK, Rout S, Mohapatra RK, Tuglo LS.   +8 more
europepmc   +1 more source

Risk management externalities in agrifood supply chains

American Journal of Agricultural Economics, EarlyView.
Abstract Firms may under‐ or over‐invest in risk management from the social planner's perspective, resulting in a negative externality on other economic agents in the supply chain. The externality of risk management is particularly relevant for agrifood supply chains, which frequently experience disruptions and play a primary role in preventing major ...
Jeffrey Hadachek, Meilin Ma
wiley   +1 more source

Preparing Adjuvanted Nanoliposomes for Applications Toward Recombinant Influenza Vaccine Development. [PDF]

Bio Protoc
Sia ZR, Huang WC, Willadsen M, Kutscher HL, Lovell JF, Davidson BA.   +5 more
europepmc   +1 more source

Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasis. [PDF]

PLoS Negl Trop Dis
Hoogerwerf MA, Egesa M, Agnandji ST, Loukas A, Roestenberg M.   +4 more
europepmc   +1 more source

Multiomic analysis identifies glutaminolysis-dependent metabolic enhancement of immune memory utilised for vaccine development. [PDF]

Nat Commun
Sowerby JM, Kotagiri P, Clare S, Griffiths D, Knight O, Cuthbertson I, Harcourt K, Pereyra Gerber P, Pshenichnaya I, Connor C, Denton A, Stoll GA, Matara C, Keel C, Manferrari G, Birkle T, Naydenova P, Peck H, Lyons PA, Barr I, Modis Y, Dougan G, Matheson NJ, Smith KGC, McKinney EF.   +24 more
europepmc   +1 more source

Systemic removal of host restriction factors enables rapid, scalable virus production for cell culture-based vaccine development. [PDF]

Front Bioeng Biotechnol
Xu Z, Jeon J, Oh J, Shin Y, Park SH.
europepmc   +1 more source

Chikungunya Virus in 2025: Epidemiology, Immunopathogenesis, and Vaccine Development - A Narrative Review. [PDF]

Infect Drug Resist
Zhao C, Ge Z, Zhang T, Jiang Z, Tian D, Chen Z.   +5 more
europepmc   +1 more source

Single-component self-assembling protein nanoparticles displaying stabilized prefusion-closed hemagglutinin trimers for influenza vaccine development. [PDF]

Nat Commun
Zhang YN, Zhu X, Braz Gomes K, Lee YZ, DesRoberts C, He L, Wilson IA, Zhu J.   +7 more
europepmc   +1 more source